Activation and Inhibition of Apoptotic Pathways by SV5

SV5 激活和抑制细胞凋亡途径

基本信息

  • 批准号:
    7091820
  • 负责人:
  • 金额:
    $ 2.77万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-07-15 至 2007-12-31
  • 项目状态:
    已结题

项目摘要

EXCEED THE SPACE PROVIDED. Apoptosis plays important roles in pathogenesis of paramyxoviruses which includes many important pathogens. Mechanisms of activation and inhibition of apoptotic pathways by paramyxoviruses are not well understood. Tumor necrosis factor alpha (TNF) can be induced by paramyxovirus infection and can cause apoptosis of infected cells. Simian virus 5 (SV5), a paramyxovirus, does not cause apoptosis. However, deletion of the 44- amino-acid-residue small hydrophobic (SH) gene from SV5 resulted in a mutant virus that induced apoptosis and increased expression of TNF. It is hypothesized that the SH protein blocks apoptotic pathways activated by TNF and the SH protein may define a new class of anti-apoptosis proteins. Long term goals of this work are to understand how paramyxoviruses interact with host cell apoptotic pathways. The proposal focuses on following aims: (1) investigate mechanism of inhibition of TNF signaling pathways by the SH protein. It is shown in the preliminary studies that the SH protein is sufficient to inhibit TNF signaling. Key residues of SH that are important for its inhibitory effect and host cells with which SH interacts will be identified; (2) investigate mechanism of increased expression of TNF in the mutant virus infected cells. Expression of TNF in virus infected cells will be examined at transcriptional and translational levels. SV5 protein responsible for activating expression will be identified; (3) study anti-apoptosis functions of SH proteins encoded by other paramyxoviruses. SV5 containing SH genes from other paramyxoviruses in place of the SH gene of SV5 will be generated. Growth characteristics of the hybrid SV5 viruses will be examined and their abilities to induce apoptosis will be analyzed; and (4) investigate inhibition of apoptotic pathways by the hemagglutinin-neuraminidase (HN) protein of SV5. Like SH, HN, a type II membrane protein, has a small cytoplasmic tail of 16 amino acid residues. A recombinant SV5 with a deletion of the tail of HN induced apoptosis in HeLa T4 cells. The involvement of the HN protein in inhibiting apoptosis will be studied. PERFORMANCE SITE ========================================Section End===========================================
超出所提供的空间。细胞凋亡在副粘病毒的发病机制中起着重要的作用,副粘病毒包括许多重要的病原体。副粘病毒激活和抑制细胞凋亡途径的机制尚不清楚。肿瘤坏死因子α (TNF)可被副粘病毒感染诱导,并可引起感染细胞凋亡。猿猴病毒5 (SV5)是一种副粘病毒,不会引起细胞凋亡。然而,从SV5中删除44-氨基酸残基小疏水(SH)基因导致突变病毒诱导细胞凋亡和TNF表达增加。据推测,SH蛋白阻断TNF激活的凋亡通路,并可能定义一类新的抗凋亡蛋白。这项工作的长期目标是了解副粘病毒如何与宿主细胞凋亡途径相互作用。本研究的主要目的是:(1)研究SH蛋白抑制TNF信号通路的机制。初步研究表明,SH蛋白足以抑制TNF信号。SH的关键残基对其抑制作用和与SH相互作用的宿主细胞很重要;(2)探讨突变病毒感染细胞中TNF表达升高的机制。TNF在病毒感染细胞中的表达将在转录和翻译水平上进行检测。鉴定激活表达的SV5蛋白;(3)研究其他副粘病毒编码的SH蛋白的抗凋亡功能。将产生含有其他副粘病毒SH基因的SV5,取代SV5的SH基因。研究杂交SV5病毒的生长特性,分析其诱导细胞凋亡的能力;(4)研究SV5的血凝素-神经氨酸酶(HN)蛋白对凋亡通路的抑制作用。与SH一样,II型膜蛋白HN也有一个由16个氨基酸残基组成的小细胞质尾部。缺失HN尾部的重组SV5诱导HeLa T4细胞凋亡。我们将进一步研究HN蛋白在抑制细胞凋亡中的作用。网站性能 ======================================== 节结束 ===========================================

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Biao He其他文献

Biao He的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Biao He', 18)}}的其他基金

Pathogenesis of Jeilongvirus
杰龙病毒的发病机制
  • 批准号:
    10197775
  • 财政年份:
    2017
  • 资助金额:
    $ 2.77万
  • 项目类别:
Mucosal Protection Against HIV Generated by PIV5 Priming and VLP Boosting
PIV5 启动和 VLP 增强产生的针对 HIV 的粘膜保护
  • 批准号:
    9029293
  • 财政年份:
    2014
  • 资助金额:
    $ 2.77万
  • 项目类别:
Mucosal Protection Against HIV Generated by PIV5 Priming and VLP Boosting
PIV5 启动和 VLP 增强产生的针对 HIV 的粘膜保护
  • 批准号:
    8706630
  • 财政年份:
    2014
  • 资助金额:
    $ 2.77万
  • 项目类别:
A Novel Approach for Mycobacterium Tuberculosis Vaccine Development
结核分枝杆菌疫苗开发的新方法
  • 批准号:
    8583108
  • 财政年份:
    2013
  • 资助金额:
    $ 2.77万
  • 项目类别:
Mechanism of Paramyxovirus Replication
副粘病毒复制机制
  • 批准号:
    8532733
  • 财政年份:
    2013
  • 资助金额:
    $ 2.77万
  • 项目类别:
A Novel Approach for Mycobacterium Tuberculosis Vaccine Development
结核分枝杆菌疫苗开发的新方法
  • 批准号:
    8660619
  • 财政年份:
    2013
  • 资助金额:
    $ 2.77万
  • 项目类别:
Mechanism of Paramyxovirus Replication
副粘病毒复制机制
  • 批准号:
    9020589
  • 财政年份:
    2013
  • 资助金额:
    $ 2.77万
  • 项目类别:
Mechanism of Paramyxovirus Replication
副粘病毒复制机制
  • 批准号:
    9114385
  • 财政年份:
    2013
  • 资助金额:
    $ 2.77万
  • 项目类别:
Mechanism of Paramyxovirus Replication
副粘病毒复制机制
  • 批准号:
    8709986
  • 财政年份:
    2013
  • 资助金额:
    $ 2.77万
  • 项目类别:
Developing a Novel Mumps Virus Vaccine
开发新型腮腺炎病毒疫苗
  • 批准号:
    8650782
  • 财政年份:
    2012
  • 资助金额:
    $ 2.77万
  • 项目类别:

相似海外基金

Molecular targeted therapy against leukemia stem cells via inhibition of anti-apoptotic proteins
通过抑制抗凋亡蛋白针对白血病干细胞进行分子靶向治疗
  • 批准号:
    16K08410
  • 财政年份:
    2016
  • 资助金额:
    $ 2.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Dual Inhibition of Mitochondrial Matrix Chaperones and Anti-Apoptotic Bcl-2 Family Members for Glioblastoma Therapy.
线粒体基质伴侣和抗凋亡 Bcl-2 家族成员的双重抑制用于胶质母细胞瘤治疗。
  • 批准号:
    9190880
  • 财政年份:
    2016
  • 资助金额:
    $ 2.77万
  • 项目类别:
Dual Inhibition of Mitochondrial Matrix Chaperones and Anti-Apoptotic Bcl-2 Family Members for Glioblastoma Therapy.
线粒体基质伴侣和抗凋亡 Bcl-2 家族成员的双重抑制用于胶质母细胞瘤治疗。
  • 批准号:
    9754260
  • 财政年份:
    2016
  • 资助金额:
    $ 2.77万
  • 项目类别:
Ethanol-mediated inhibition of the S1P lyase results in disruption of apoptotic machinery and lymphocyte egress from lymphoid tissue
乙醇介导的 S1P 裂解酶抑制导致细胞凋亡机制破坏和淋巴细胞从淋巴组织中流出
  • 批准号:
    9142978
  • 财政年份:
    2015
  • 资助金额:
    $ 2.77万
  • 项目类别:
Optimizing Pro-Apoptotic Therapeutics With Kinase Inhibition in Neuroblastoma
通过激酶抑制优化神经母细胞瘤的促凋亡治疗
  • 批准号:
    7938472
  • 财政年份:
    2009
  • 资助金额:
    $ 2.77万
  • 项目类别:
Optimizing Pro-Apoptotic Therapeutics With Kinase Inhibition in Neuroblastoma
通过激酶抑制优化神经母细胞瘤的促凋亡治疗
  • 批准号:
    8296113
  • 财政年份:
    2008
  • 资助金额:
    $ 2.77万
  • 项目类别:
Optimizing Pro-Apoptotic Therapeutics With Kinase Inhibition in Neuroblastoma
通过激酶抑制优化神经母细胞瘤的促凋亡治疗
  • 批准号:
    8098884
  • 财政年份:
    2008
  • 资助金额:
    $ 2.77万
  • 项目类别:
Optimizing Pro-Apoptotic Therapeutics With Kinase Inhibition in Neuroblastoma
通过激酶抑制优化神经母细胞瘤的促凋亡治疗
  • 批准号:
    7843564
  • 财政年份:
    2008
  • 资助金额:
    $ 2.77万
  • 项目类别:
Optimizing Pro-Apoptotic Therapeutics With Kinase Inhibition in Neuroblastoma
通过激酶抑制优化神经母细胞瘤的促凋亡治疗
  • 批准号:
    7471620
  • 财政年份:
    2008
  • 资助金额:
    $ 2.77万
  • 项目类别:
Optimizing Pro-Apoptotic Therapeutics With Kinase Inhibition in Neuroblastoma
通过激酶抑制优化神经母细胞瘤的促凋亡治疗
  • 批准号:
    7919179
  • 财政年份:
    2008
  • 资助金额:
    $ 2.77万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了